Navigation Links
Naglazyme Approved by Brazil's National Health Surveillance Agency
Date:2/3/2009

NOVATO, Calif., Feb. 3 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that ANVISA, Brazil's National Health Surveillance Agency, has granted BioMarin marketing approval for Naglazyme(R) (galsulfase) for the treatment of patients with Mucopolysaccharidosis VI (MPS VI).

"We are very pleased to receive marketing approval for Naglazyme in Brazil which has the largest known number of affected MPS VI patients in the world," said Stephen Aselage, Senior Vice President of Global Commercial Development at BioMarin. "Although there is no formal orphan drug designation in Brazil, ANVISA approved Naglazyme in just eight months based on a recent resolution that gives priority review for therapies that are developed for the treatment of neglected diseases or are considered orphan disorders. This emphasizes the need to rapidly bring life-altering therapies to patients around the world, and we remain dedicated to pursuing continued geographic expansion and are optimistic regarding the long-term potential of Naglazyme."

Naglazyme was approved by the U.S. Food and Drug Administration (FDA) in May 2005 and by the European Commission (EC) in January 2006. As the first drug approved for MPS VI, the FDA and EC have both designated Naglazyme as an orphan drug, conferring seven years of market exclusivity in the United States and 10 years of market exclusivity in the European Union.

About MPS VI

MPS VI (also known as Maroteaux-Lamy syndrome) is a debilitating, life-threatening genetic disease caused by a deficiency of the enzyme N-acetylgalactosamine 4-sulfatase. This enzyme deficiency leads to the accumulation of certain complex carbohydrates, glycosaminoglycans (GAGs), in the lysosomes, giving rise to progressive cellular, tissue and organ system dysfunction. The majo
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Naglazyme Approved by Japanese Ministry of Health
2. Kuvan, Naglazyme and Aldurazyme Data to Be Presented at the 57th Annual Meeting of the American Society of Human Genetics
3. Watsons GELNIQUE(TM) (oxybutynin chloride) Gel 10% Approved by FDA for the Treatment of Overactive Bladder
4. Neogens BetaStar(R) US Dairy Antibiotic Test Approved by FDA/NCIMS
5. First U.S. Implants of Newly Approved Embozene(TM) Color-Advanced Microspheres Embolization Platform
6. Video: Allergan Announces U.S. Food and Drug Administration (FDA) Approval of Latisse(TM) -- First and Only Treatment Approved by the FDA for Hypotrichosis of Eyelashes
7. Pharmaxis Aridol Approved for Sale in Switzerland
8. China-Biotics, Inc. Approved to List on the Nasdaq Global Market
9. CSMG Technologies Announces Key Fifth U.S. Tissue Bonding/Welding Patent Approved
10. ARIUS sale approved by shareholders
11. Video: Keppra XR(TM) Approved in the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... Cleveland, Ohio (PRWEB) July 10, 2014 ... in ion channel-expressing cell lines, and the gap that ... new cells that expand its industry-leading portfolio of validated ... focuses on ion channel-expressing cell lines, as ion channels ... able to control this activity creates the potential to ...
(Date:7/10/2014)... CA (PRWEB) July 10, 2014 OMICS ... Bioanalytical techniques during 18-20 August, 2014 at Double Tree ... review the recent developments in Analytical & Bioanalytical research ... globe. , Speaking on this occasion, Dr. Srinubabu Gedela, ... Analytica Acta conference is a remarkable one in bringing ...
(Date:7/10/2014)... July 10, 2014 On July ... Medvedev , presented Russia,s first ... . The Company is developing a unique project called ... BIOCAD develops a number of innovative drugs based on ... The ceremony took place at the International Exhibition "Innoprom ...
(Date:7/10/2014)... OAKS, Calif., July 10, 2014   Ceres, Inc ... and seed company, announced today financial results for the ... update on its business. Ceres reported that ... in product performance this growing season in Brazil, which ... affected the company,s sorghum evaluation areas for part of ...
Breaking Biology Technology:Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 2Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 3A Critical Review of Analytical Techniques for Improved Living Standards 2A Critical Review of Analytical Techniques for Improved Living Standards 3A Critical Review of Analytical Techniques for Improved Living Standards 4Dmitry Medvedev Presented BIOCAD the First National "Industry" Award 2Ceres Announces Fiscal Third Quarter 2014 Financial Results 2Ceres Announces Fiscal Third Quarter 2014 Financial Results 3Ceres Announces Fiscal Third Quarter 2014 Financial Results 4Ceres Announces Fiscal Third Quarter 2014 Financial Results 5Ceres Announces Fiscal Third Quarter 2014 Financial Results 6Ceres Announces Fiscal Third Quarter 2014 Financial Results 7Ceres Announces Fiscal Third Quarter 2014 Financial Results 8Ceres Announces Fiscal Third Quarter 2014 Financial Results 9
... MRIGlobal, an internationally recognized research and development organization ... has appointed Richard A. Winegar, Ph.D., to Principal Advisor ... Dr. Winegar is a recognized expert in ... genetic toxicology.  As Principal Advisor for Science, he will ...
... July 11, 2011 Avisena, one of the nation,s ... for physician practices, today announced the extension of a ... facility will be used to accelerate the Company,s strategic ... and marketing. "Square 1 believes in supporting ...
... Pharma, Inc. is pleased to announce that it has ... its lead drug for the treatment of stroke and ... A Phase 1, Open-Label, Randomized, Two-Period, Two-Treatment, Two-Sequence, Single ... of Oral and Intravenous Administration of Methamphetamine Hydrochloride in ...
Cached Biology Technology:MRIGlobal Appoints Richard A. Winegar, Ph.D., as Principal Advisor for Science 2Avisena Closes $2.5 Million of Debt Capital By Square 1 Bank 2Sinapis Pharma Completes Phase I Trial 2
(Date:7/14/2014)... oxygen control insect body size? What influence does genetics have ... of Current Opinion in Insect Science launched ... Current Opinion in Insect Science is the latest ... review journal that aims to provide specialists with a unique ... published in the field of insect science. First articles published ...
(Date:7/14/2014)... with roots in the local environment manage much better ... from foreign environments. , A world without bees ... Denmark alone an additional 600 million to 1 billion ... done by bees making honey and pollinating a wide ... , Unfortunately, bees all over the world are under ...
(Date:7/14/2014)... genes that improved the harvesting of sunlight, a new ... genomes reveals. The findings could help current efforts to ... a ,genetic snapshot, of maize as it existed 10 ... of its genome a ,whole genome duplication, event. ... ,copied, genes to cope with the pressures of domestication, ...
Breaking Biology News(10 mins):Best for bees to be stay-at-homes 2A-maize-ing double life of a genome 2
... gases and increase production at the same time has been ... Industries' (DPI) Wollongbar Agricultural Institute. , Trials of agrichar - ... and the environment - have doubled and, in one case, ... tonnes per hectare. , Agrichar is a black ...
... tiger now occupies a mere 7 percent of its historic ... has declined by 41 percent over the past decade, according ... BioScience. Growing trade in folk medicines made from tiger parts ... believed to be the chief reason for the losses. The ...
... long been clear that smoking causes cancer, but new research ... who smokes. , Canadian researchers have demonstrated in ... of sperm cells, alterations that could potentially be inherited by ... June 1 issue of Cancer Research, a journal of the ...
Cached Biology News:Soils offer new hope as carbon sink 2Soils offer new hope as carbon sink 3Threats to wild tigers growing 2Cigarette smoke alters DNA in sperm, genetic damage could pass to offspring 2
Mouse monoclonal antibody raised against a partial recombinant EBI3. NCBI Entrez Gene ID = EBI3...
... AS-2055 and AS-2057 are fully automatic sample ... possible level of precision. Sampling flexibility is ... (microplate) for,laboratory automation and combinatorial chemistry. Also ... or the standard rack for 50 2,ml ...
...
... Covance's BCIP/NBT Chromogen system ... Tetrazolium] chromogen in a single ... reacts in the presence of ... purple staining with minimal background ...
Biology Products: